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Abstract 
Background: The value of goal-directed fluid therapy in neurosurgical patients, where brain swelling is a major con-
cern, is unknown. The aim of our study was to evaluate the effect of an intraoperative goal-directed fluid restriction 
(GDFR) strategy on the postoperative outcome of high-risk patients undergoing brain surgery.
Methods: High-risk patients undergoing brain surgery were randomly assigned to a usual care group (control group) 
or a GDFR group. In the GDFR group, (1) fluid maintenance was restricted to 3 ml/kg/h of a crystalloid solution and 
(2) colloid boluses were allowed only in case of hypotension associated with a low cardiac index and a high stroke 
volume variation. The primary outcome variable was ICU length of stay, and secondary outcomes were lactates at the 
end of surgery, postoperative complications, hospital length of stay, mortality at day 30, and costs.
Results: A total of 73 patients from the GDFR group were compared with 72 patients from the control group. 
Before surgery, the two groups were comparable. During surgery, the GDFR group received less colloid (1.9 ± 1.1 vs. 
3.9 ± 1.6 ml/kg/h, p = 0.021) and less crystalloid (3 ± 0 vs. 5.0 ± 2.8 ml/kg/h, p < 0.001) than the control group. ICU 
length of stay was shorter (3 days [1–5] vs. 6 days [3–11], p = 0.001) and ICU costs were lower in the GDFR group. 
The total number of complications (46 vs. 99, p = 0.043) and the proportion of patients who developed one or more 
complications (19.2 vs. 34.7%, p = 0.034) were smaller in the GDFR group. Hospital length of stay and costs, as well as 
mortality at 30 day, were not significantly reduced.
Conclusion: In high-risk patients undergoing brain surgery, intraoperative GDFR was associated with a reduction in 
ICU length of stay and costs, and a decrease in postoperative morbidity.
Trial registration Chinese Clinical Trial Registry ChiCTR-TRC-13003583, Registered 20 Aug, 2013
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Background
Perioperative fluid administration has been shown to be 
a major determinant of postoperative outcome [1]. The 
amount of fluid administered during the perioperative 
period depends on multiple factors such as preoperative 
hydration, intraoperative blood loss, hemodynamic stabil-
ity, as well as habits and believes of anesthesiologists and 
surgeons [2]. Fluid needs may be highly variable from one 
patient to the other and are hardly predictable from clas-
sical physiological parameters such as heart rate, blood 
pressure, and central venous pressure. Fluid titration 
based on the measurements of advanced hemodynamic 
parameters, such as cardiac output and dynamic predic-
tors of fluid responsiveness, has been shown to be use-
ful to improve the outcome of patients undergoing major 
abdominal, vascular, and orthopedic procedures [3–6].
Whether such strategies may also be useful in patients 
undergoing brain surgery is unknown. In this specific 
context, the temptation is to keep patients as dry as 
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possible to prevent brain swelling. However, blinded 
or uncontrolled fluid restriction may expose patients to 
hypovolemia-related complications [1]. We hypothesized 
that advanced hemodynamic measurements may be use-
ful to objectively balance the risks of fluid restriction 
(hypovolemia, hypotension, and cerebral ischemia) with 
the risk of inducing or worsening cerebral edema [7, 8]. 
In line with this concept, we designed an intraoperative 
fluid management protocol where minimal fluid mainte-
nance with a crystalloid solution (fluid restriction) was 
combined with the administration of fluid boluses in case 
of severe and documented hypovolemia.
The goal of the present study was therefore to assess 
the effects of an intraoperative goal-directed fluid restric-
tion (GDFR) strategy on the postoperative outcome of 
high-risk patients undergoing brain surgery.
Methods
Patient selection
Adult patients undergoing elective craniotomy for brain 
tumor resection, brain abscess, or intracranial aneu-
rysm were considered for enrollment. Inclusion criteria 
were age >18, ASA score III or IV, and expected dura-
tion of surgery >2 h. Patients with a body weight <40 kg 
or >100  kg were excluded, as well as patients with car-
diac arrhythmia (well-known limitation to the use of the 
stroke volume variation as an indicator of fluid respon-
siveness) [9]. The study was approved by the Ethical 
Committee of the West China Hospital from Sichuan 
University (No. 2012-104). After obtaining written 
informed consent, patients were randomly assigned to 
a standard fluid management group (Control) or to a 
GDFR group. A random number table was used to gener-
ate the random number sequence. All random numbers 
were concealed in sealed envelopes and assigned to a 
patient when entering the operating room.
Intraoperative monitoring and management
In addition to pulse oximetry, capnography, and heart 
rate monitoring, all patients had a radial arterial line in 
place for continuous blood pressure monitoring and 
a BIS sensor in place to monitor depth of anesthesia. 
Tidal volume was set at 8  ml/kg and respiratory fre-
quency was adapted to maintain end-tidal CO2 between 
30 and 35  mmHg. Anesthesia induction was done with 
propofol (2  mg/kg) and rocuronium (1  mg/kg), and 
then propofol and remifentanil were used to maintain 
depth of anesthesia (BIS in the range 40–60). Body tem-
perature was maintained close to normal using warmed 
solutions and insulation blankets. Per our neurosurgical 
policy, all patients received mannitol the day before sur-
gery (250 ml), at the beginning of the surgical procedure 
(250 ml), and the day after surgery (125 ml).
In the control group, no recommendation was given for 
fluid and hemodynamic management during and after 
surgery, and therapeutic decisions were left at the discre-
tion of the attending anesthesiologist and intensivist. In 
the GDFR group and during surgery, fluid maintenance 
was set at 3  ml/kg/h of normal saline with an infusion 
pump, and additional colloid (gelatins or hydroxyethyl 
starches) boluses (200  ml) were allowed only in case of 
systemic hypotension (MAP < 65 mmHg) with a cardiac 
index (CI) <2.5  l/min/m2 and a stroke volume variation 
(SVV) >15%. In case of hypotension with a CI >2.5, the 
recommendation was to give a vasopressor. If CI was <2.5 
and SVV <15%, the recommendation was to give an ino-
trope. The FloTrac/Vigileo system (Edwards Lifesciences, 
Irvine, CA) was used to continuously monitor CI and 
SVV.
Outcome variables
The primary outcome variable was ICU length of stay. 
Secondary outcome variables were lactates at the end of 
surgery, postoperative complications at day 30, postop-
erative morbidity (the proportion of patients who devel-
oped one or more complications) at day 30, mortality at 
day 30, hospital length of stay, and costs.
Statistical analysis
Median ICU length of stay was 5 ± 1.6 days in our insti-
tution, and we assumed that GDFR may decrease it by 
1 day or 20%. A study sample size of 60 patients in each 
group was calculated for two-sided tests with type I error 
of 5% and power of 90%. Owing to an anticipated loss of 
several patients entering the study, we planned to include 
75 patients in each group. For a test of normal distribu-
tion, the Kolmogorov–Smirnov test was used. Continu-
ous data with normal distribution were tested with paired 
or unpaired t tests, non-normally distributed data using 
Mann–Whitney U test and Wilcoxon rank-sum test for 
unpaired and paired results, respectively. Changes in 
lactate over time were tested using analysis of variance 
(ANOVA) on repeated measurements. Categorical data 
were tested using Chi-square test and Chi-square test for 
trend. Data are presented as mean ± standard deviation 
when normally distributed and as median [interquartile 
ranges] in case of abnormal distribution. A p < 0.05 was 
considered statistically significant for all tests. All calcu-
lations were done with MedCalc® version 10.4.8.0 (Med-
Calc Software, Mariakerke, Belgium).
Results
A total of 150 patients were randomized (75 in each 
group). Despite preoperative approval, five patients 
refused to participate in the study after surgery and had 
to be excluded from the analysis. Thus, 73 patients from 
Page 3 of 7Luo et al. Ann. Intensive Care  (2017) 7:16 
the GDFR group were compared to 72 patients from the 
control group.
Baseline and surgical characteristics
Reasons for surgery were brain tumor (n =  87), intrac-
ranial aneurysm (n =  55), or brain abscess (n =  3) and 
were well balanced between the two groups (Table  1). 
The GDFR group and the control group were compara-
ble in terms of age, comorbidities, ASA score, and POS-
SUM score (Table  1). Surgery duration was comparable 
in both groups as well as intraoperative estimated blood 
loss (Table 2). During surgery, the GDFR group received 
significantly less colloid and crystalloid than the control 
group (Table 2).
Outcome variables
The ICU length of stay was significantly shorter in the 
GDFR group (3 days [1–5] vs. 6 days [3–11], p = 0.001) 
(Fig.  1). At the end of the surgical procedure, lac-
tates were lower in the GDFR group (1.79  ±  0.85 vs. 
2.23  ±  1.36  mmol/l, p  =  0.003). The total number of 
complications and the proportion of patients who devel-
oped one or more postoperative complications were 
lower in the GDFR group, as well as ICU costs (Table 3). 
Median hospital length of stay was decreased by 2 days, 
but the difference did not reach statistical significance 
(Table 3). No differences were found in heart rate, mean 
arterial pressure, PETCO2, natremia, and urine output 
during the surgery between the two groups (Table 4).
Discussion
In high-risk patients undergoing brain surgery, our 
study shows that the use of GDFR was associated with a 
decrease in fluid volumes, less postoperative complica-
tions, and a shorter ICU length of stay.
Many studies have investigated the value of goal-
directed fluid therapy in patients undergoing major 
abdominal, vascular, and orthopedic surgeries [3–6]. 
Conflicting results have been reported, but recent meta-
analysis [3–6] has suggested an overall reduction in post-
operative morbidity around 25–50%, associated with a 
1–2-day reduction in hospital length of stay. As far as we 
know, this is the first study investigating the effects of a 
goal-directed fluid strategy in patients undergoing brain 
surgery. The main objective of goal-directed strategies 
is to rationalize the way fluid is administered during the 
perioperative period [10]. A U-shaped relationship has 
been described between the perioperative fluid volume 
and postoperative complications [1]. Patients who do not 
receive enough fluid may develop complications related 
to hypovolemia, such as acute renal failure, myocardial 
injury, and cerebral ischemia. On the other hand, patients 
receiving too much fluid may develop complications 
associated with fluid overload, such as tissue edema, 
which may be responsible for prolonged mechanical ven-
tilation and delayed wound healing [11].
For specific surgical procedures, such as pneumonec-
tomy, liver resection, and neurosurgery, the temptation 
has always been to keep patients as dry as possible to 
prevent pulmonary edema, surgical bleeding, and brain 
swelling, respectively. However, blinded or uncontrolled 
fluid restriction may expose patients to hypovolemia-
related complications [1, 12]. We hypothesized that 
advanced hemodynamic measurements may be useful 
to prevent both insufficient and excessive fluid manage-
ment and improve postoperative outcome. We therefore 
designed an intraoperative fluid management protocol 
where minimal fluid maintenance with a crystalloid solu-
tion (fluid restriction) was combined with the adminis-
tration of fluid boluses only in case of severe hypovolemia 
defined by the association of a low cardiac index with a 
high SVV. The SVV has been shown to be useful to pre-
dict fluid responsiveness in many different settings [13]. 
Pending limitations are respected [9]; SVV >10–13% 
Table 1 Preoperative characteristics of  the study popula-
tion
Values are presented as mean ± standard deviation
POSSUM physiological and operative severity score for the enumeration of 






Male/female 30:43 32:40 0.738
Age 61 ± 13 62 ± 13 0.693
Age ≥ 70 years 20 24 0.474
Weight (kg) 59 ± 11 60 ± 12 0.417
Height (cm) 160 ± 8 162 ± 7 0.105
POSSUM (physiology score) 21 ± 7 23 ± 6 0.151
POSSUM (operative score) 13 ± 4 13 ± 3 0.394
ASA (3:4) 70:3 70:2 1.000
Comorbidities
 Coronary artery disease 5 7 0.563
 Hypertension 45 37 0.243
 Peripheral artery disease 0 0 1.000
 COPD 11 18 0.151
 Other pulmonary pathol-
ogy
4 5 0.745
 Cerebrovascular disease 26 29 0.610
 Diabetes mellitus 10 11 0.818
 Chronic kidney disease 1 1 0.992
 Malignancy 33 30 0.738
Diagnosis
 Intracranial aneurysm 26 29 0.610
 Intracranial mass 46 41 0.500
 Brain abscess 1 2 0.620
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identifies fluid responder patients with high sensitiv-
ity and specificity [13]. We decided to use a higher cut-
off value to keep our patients on the “dry” side, but we 
also decided to allow fluid boluses when SVV was >15% 
to prevent excessive fluid restriction and hypovolemia-
related complications. Goal-directed fluid strategies 
have the advantage to rationalize the way patients are 
treated [10]. However, we believe that fluid management 
protocols must be adapted to clinical and surgical situa-
tions. The use of high SVV target values (around 18–20%) 
has recently been proposed in patients undergoing liver 
resection to limit surgical bleeding as much as possi-
ble [14]. We thought it might be wise to adopt a similar 
strategy in neurosurgical patients to minimize cerebral 
edema. With our GDFR protocol, patients received less 
crystalloid and colloid than the control group, but did not 
Table 2 Patient characteristics during and 24 h after surgery
Values are presented as mean ± standard deviation
CI cardiac index, HR heart rate, MAP mean arterial pressure, N/A not applicable, SVV stroke volume variation
GDFR group (n = 73) Control group (n = 72) p value
Patient position
 Supine position (n) 41 45 0.500
 Left-lateral position (n) 18 14 0.549
 Right-lateral position (n) 12 10 0.818
 Prone position (n) 2 3 0.679
Beginning of surgery
 CI (ml/min/m2) 3 ± 1.2 NA NA
 SVV (%) 12 ± 5 NA NA
During surgery
 Crystalloids (ml/kg/h) 3 ± 0 5.0 ± 2.8 <0.001
 Colloids (ml/kg/h) 1.9 ± 1.1 3.9 ± 1.6 0.021
 Colloids (ml) 563 ± 550 1050 ± 548 <0.001
 Colloids (nb of bolus per patient) 3 ± 3 5 ± 3 <0.001
 Autologous blood transfusion (ml) n = 5, 280 ± 109 n = 14, 375 ± 198 0.224
 Red blood cell (ml) n = 3, 400 ± 200 n = 2, 400 ± 282 0.089
 Fresh frozen plasma (ml) 0 0 1
 Estimated blood loss (ml) 287 ± 179 305 ± 273 0.535
 Metaraminol (no. of patients) 39 18 <0.001
 Ephedrine (no. of patients) 40 21 <0.001
 Dopamine (no. of patients) 5 3 0.479
 Dobutamine (no. of patients) 1 0 0.319
 Norepinephrine (no. of patients) 3 3 0.981
End of surgery
 CI (ml/min/m2) 3.6 ± 0.7 NA NA
 SVV (%) 7 ± 2 NA NA
 Length of surgery (min) 274 ± 72 276 ± 66 0.864
 Dopamine (n) 1 0 0.319
 Norepinephrine (n) 0 1 0.312
24 h after surgery
 Crystalloids (ml/kg/h) 2.6 ± 1.3 2.6 ± 0.8 0.881
 Colloids (ml/kg/h) 0.2 ± 0.3 0.2 ± 0.3 0.868
 Blood (ml/kg/h) 0 0 0.746
 Fresh frozen plasma (ml) 0 0 0.744
 Estimated blood loss (ml) 98 ± 65 115 ± 99 0.206
 Norepinephrine (n) 3 3 0.981
 Dopamine (n) 5 3 0.479
 Vasodilatation therapy (n) 5 11 0.105
 Diuretic support (n) 45 38 0.281
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develop more often hypovolemia-related complications 
such as acute kidney and myocardial injury.
Our study also showed a significant reduction in ICU 
costs with GDFR, which is logical when considering the 
observed reduction in ICU length of stay, likely related 
to the lower number of patients who developed compli-
cations (Table  3). Sadique et  al. [15] recently reported 
the financial results of the large UK Optimise trial and 
showed that patients treated with goal-directed fluid 
therapy were on average £400 less expensive to treat than 
control patients. In patients undergoing head and neck 
surgery in the USA, in whom ICU length of stay was sig-
nificantly reduced when using goal-directed fluid ther-
apy, Hand et al. [16] recently reported savings exceeding 
$3000 per patient. Surgical and anesthesia costs in China 
are not comparable to those observed in the UK or in the 
USA. However, as suggested by previous studies [17, 18] 
our financial findings confirm that the improvement in 
postoperative outcome may offset the costs associated 
with the implementation of goal-directed fluid therapy.
Our study has several limitations. First, this is a sin-
gle-center study where we compared a GDFR strategy 
to standard hemodynamic management at West China 
Hospital in Chengdu, Sichuan. We also focused on high-
risk patients (ASA III & IV). Thus, our results may not be 
extrapolated to other institutions having different anes-
thesia and surgical practices, as well as to low-risk (ASA 
I & II) neurosurgical patients. Three patients had a brain 
abscess and did not require emergency surgery. Thus, 
they were considered as elective patients and enrolled 
in our study. We acknowledge their specificity but con-
firm that similar results were observed after excluding 
them from the analysis. Although based on physiological 
rational, the 15% cutoff value used for SVV was arbitrary 
and other studies would be useful to investigate whether 
better results could be observed when using lower (e.g., 
13%) or higher (e.g., 18%) cutoff values. Also, we can-
not draw any conclusion regarding the superiority of 
Fig. 1 Length of stay in the intensive care unit (ICU) in the goal-
directed fluid restriction (GDFR) and in the control groups
Table 3 Postoperative outcome
Values are presented as mean ± standard deviation
ICU intensive care unit, AKI acute kidney injury





ICU length of stay 
(days)
3 (1–5) 6 (3–11) 0.001
Mortality (n/%) 4/5.5 9/12.5 0.158
Hospital length of stay 
(days)
15 (7–23) 17 (9–27) 0.069
Complications (day 30)
 Total (n) 46 99 0.043




 Vomiting (n/%) 2/2.7 2/2.8 0.989
 Coma (n/%) 3/4.1 2/2.8 0.660




 Pneumonia (n/%) 9/12.3 20/27.8 0.020
 Sepsis (n/%) 0/0 2/2.8 0.152
 Ventilator support 
(n/%)
6/8.2 12/16.7 0.123
 New onset of ventila-
tor support (n/%)
3/4.1 8/11.1 0.111
 AKI (without dialysis) 
(n/%)
3/4.1 5/6.9 0.455
 Renal failure with 
dialysis (n/%)
0/0 1/1.4 0.312
 Stroke (including TIA) 
(n/%)
1/1.4 0/0 0.319
 Deep vein thrombosis 
(n/%)
0/0 4/5.6 0.041






 Skin lesions (n/%) 8/11.0 16/22.2 0.068
 Arrhythmias (non-life 
threatening) (n/%)
1/1.4 2/2.8 0.552






 Acute myocardial 
infarction (n/%)
0/0 0/0 1




 Hospital costs ($) 9218 ± 2890 10,249 ± 3175 0.482
 ICU costs ($) 1776 ± 459 3080 ± 700 0.037
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our original GDFR strategy over a more classical goal-
directed fluid strategy (e.g., stroke volume optimiza-
tion) or over fluid restriction alone. The reliability of 
the FloTrac/Vigileo system to measure cardiac output 
has been questioned when compared to clinical refer-
ence techniques such as pulmonary thermodilution and 
echocardiography [19]. Of note, most limitations have 
been described in patients with septic shock receiving 
vasopressors, or during liver transplantation [20]. Recent 
meta-analysis of validation studies suggests that both 
accuracy and precision are comparable to those observed 
with other continuous cardiac output monitoring tech-
niques currently available on the market [21]. And many 
studies have demonstrated that FloTrac-derived SVV is 
an accurate predictor of fluid responsiveness; pending 
limitations are respected [20].
Conclusion
In high-risk patients undergoing brain surgery, our intra-
operative GDFR strategy was associated with a significant 
decrease in ICU length of stay, costs, and postoperative 
complications. Larger studies are needed to confirm our 
findings and assess the impact on hospital length of stay 
and hospital finances.
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Table 4 Patient characteristics during surgery
Values are presented as mean ± standard deviation
MAP mean arterial pressure, PETCO2 peak end-tidal CO2
Variable Beginning of surgery 1 h 2 h 3 h 4 h End of surgery
Number
 GDFR group 73 (100%) 73 (100%) 73 (100%) 36 (49%) 25 (34%) 73 (100%)
 Control group 72 (100%) 72 (100%) 72 (100%) 37 (51%) 24 (33%) 72 (100%)
 p value 1.00 1.00 1.00 0.80 0.92 1.00
MAP (mmHg)
 GDFR group 83 ± 14 75 ± 9 77 ± 10 77 ± 11 73 ± 9 82 ± 11
 Control group 80 ± 15 78 ± 11 80 ± 14 76 ± 11 82 ± 11 78 ± 11
 p value 0.17 0.09 0.16 0.93 0.12 0.07
PETCO2 (mmHg)
 GDFR group 29 ± 3 29 ± 4 29 ± 3 29 ± 3 29 ± 3 31 ± 4
 Control group 30 ± 3 29 ± 3 29 ± 3 30 ± 3 32 ± 4 28 ± 3
 p value 0.20 0.68 0.69 0.44 0.06 0.79
Sodium (mmol/l)
 GDFR group 137.8 ± 4.8 134.5 ± 5.7 135.9 ± 4.7 136.8 ± 5.5 136.2 ± 3.3 137.3 ± 4.5
 Control group 136.0 ± 5.5 134.3 ± 5.8 136.1 ± 5.2 137.4 ± 5.3 139.0 ± 6.7 137.5 ± 5.1
 p value 0.03 0.81 0.86 0.64 0.07 0.84
Diuresis (ml/kg/h)
 GDFR group 0 5.58 ± 1.74 5.19 ± 1.37 4.97 ± 1.85 4.41 ± 1.73 4.12 ± 1.39
 Control group 0 5.76 ± 1.50 5.52 ± 1.77 5.03 ± 1.63 5.01 ± 1.45 4.12 ± 1.39
 p value 1 0.52 0.18 0.92 0.26 0.80
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